Cadrenal Therapeutics CVKD
NASDAQ CVKD
$0.95 -0.02 (-2.09%)
As of: Oct 2, 2026 · 3:22 PM EDT

Cadrenal Therapeutics (CVKD) Return on Assets [ROA] (2023 - 2026)

Updated

Cadrenal Therapeutics (CVKD) reported Return on Assets [ROA] of -279.03% for Q2 2026, down 133.59 percentage points from -145.44% a year earlier.

Analysis

Cadrenal Therapeutics (CVKD) Return on Assets [ROA] (2023 - 2026) Analysis & Trends

For FY2023, Cadrenal Therapeutics posted Return on Assets [ROA] of -158.83%.

  • The Q2 2026 figure ranks as the lowest quarterly Return on Assets [ROA] in data going back to Q1 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.47%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.65%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.45%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 28.37%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.10%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 9.29%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -6.13%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.14%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 16.34%
10 Cadrenal Therapeutics 3.35 Mn -9.27 Mn - -279.03%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -279.03%
Jun 30, 2025 -145.44%
Sep 30, 2024 -150.11%
Jun 30, 2024 -99.74%
Mar 31, 2024 -62.27%
Dec 31, 2023 -82.86%
Sep 30, 2023 -114.02%
Jun 30, 2023 -181.25%
Mar 31, 2023 -257.52%
API Access

Cadrenal Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=CVKD&period=max&api_key=YOUR_API_KEY